GHRP-6
Growth Hormone Releasing Peptide-6, Growth hormone-releasing hexapeptide, His-D-Trp-Ala-Trp-D-Phe-Lys-NH2
Tetrahydroisoquinoline 1-carboxamides as growth hormone secretagogues.
Li. James J JJ; Wang. Haixia H; Qu. Fucheng F; Musial. Christa C; Tino. Joseph A JA; Robl. Jeffrey A JA; Slusarchyk. Dorothy D; Golla. Rajasree R; Seethala. Ramakrishna R; Dickinson. Kenneth K; Giupponi. Leah L; Grover. Gary G; Sleph. Paul P; Flynn. Neil N; Murphy. Brian J BJ; Gordon. David D; Kung. Melissa M; Stoffel. Robert R
Key Findings
- Novel tetrahydroisoquinoline 1‑carboxamides act as potent growth hormone secretagogues.
- Carbamate 12a‑E2 increased plasma GH 10‑fold in an IV rat model under anesthesia.
- The compounds are still in early pre‑clinical stages and not tested in humans.
Practical Outcomes
- For biohackers, this research shows that new GH‑boosting molecules are being explored, but there is no actionable protocol or dosage to apply. It does not change how GHRP‑6 is used, and the findings are not directly translatable to human self‑experimentation at this time.
Summary
Scientists made a new class of chemicals that can boost growth hormone in rats, with one version (carbamate 12a‑E2) raising GH levels about ten times. However, these compounds are experimental, not available to the public, and the study used an anesthetized rat model, so it doesn't give direct guidance for human use or for the peptide GHRP‑6.
Abstract
Several novel series of tetrahydroisoquinoline 1-carboxamides were prepared and shown to be potent growth hormone (GH) secretagogues. Among them, carbamate 12a-E2 displays excellent in vivo activity by increasing plasma GH 10-fold in an anesthetized IV rat model.
Study Information
pubmed
2005
2005-04-01T00:00:00.000Z
10.1016/j.bmcl.2005.02.040